Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Amid debt dispute, Electro Optic Systems reports revenue guidance of $210 to $230 million
    • News

    Amid debt dispute, Electro Optic Systems reports revenue guidance of $210 to $230 million

    In the midst of a debt dispute with a major lender, Australian security technology company Electro Optic Systems (ASX: EOS), which operates in the defence and space sectors, has announced a robust revenue projection for the calendar year 2023. The Company anticipates its revenue to range between $210 million and $230 million for CY23. This

    Read More
    Public
  • Use your mobile to check for arrhythmia as Advanced Health Intelligence launches AF-Scan
    • News

    Use your mobile to check for arrhythmia as Advanced Health Intelligence launches AF-Scan

    HealthTech company Advanced Health Intelligence (ASX: AHI) is set to launch a medically-approved mobile phone-based atrial fibrillation (AF) assessment in Q2 CY24 in collaboration with Belgium-based Qompium NV, a company specialising in mobile scanning tech.  Globally, there are about 60 million cases of atrial fibrillation (AF), which is a form of arrhythmia involving irregular heartbeat.

    Read More
    Public
  • The Calmer Co reports monthly record of eCommerce kava sales thanks to Black Friday
    • News

    The Calmer Co reports monthly record of eCommerce kava sales thanks to Black Friday

    Derived from the roots of the Piper methysticum plant native to the Pacific Islands, Kava has gained popularity for its potential health benefits as evidenced by The Calmer Co (ASX: CCO), which reported $110,000 in sales through the month of November for it’s eCommerce channels. These sales primarily came from The Calmer Co’s online Shopify

    Read More
    Public
  • US markets see late drive higher, XJO to open flat
    • Market Update

    US markets see late drive higher, XJO to open flat

    The XJO is expected to open flat this morning following a continued move sideward from the U.S overnight. Their market finished marginally higher, and their futures are flat this morning. Yesterday we had a moment of uncharacteristic clarity as we extended the previous sessions’ gains with a strong move higher. The cause for the vigour

    Read More
    Public
  • Little Green Pharma has big news: a new CEO and 37% revenue growth
    • News

    Little Green Pharma has big news: a new CEO and 37% revenue growth

    Over the years, the Australian cannabis market has consistently posted revenue growth and is expected to be valued at $1.1 billion by 2028. Both Aussies and Europeans are big consumers of cannabis, making them attractive markets for medical cannabis companies like Little Green Pharma (ASX: LGP).  Little Green Pharma posted a 37% revenue spike to

    Read More
    Public
  • The BESS-T bet: GenusPlus and Samsung joint venture awarded $200m to build energy solution
    • News

    The BESS-T bet: GenusPlus and Samsung joint venture awarded $200m to build energy solution

    National power and communications infrastructure provider GenusPlus (ASX: GNP) has secured three contracts in collaboration with Samsung C&T Corporation. These contracts with the Melbourne Renewable Energy Hub (MREH) include the engineering, procurement, construction, and commissioning of the Balance of Plant scope (i.e. the supporting components of a power plant), as well as the installation of

    Read More
    Public
  • «
  • ‹
  • 145
  • 146
  • 147
  • 148
  • 149
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.